Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02060344 · ClinicalTrials.gov registry record

Hispanic Community Health Study / Study of Latinos

A clinical trial of Cardiovascular Disease, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Active
Registry status
16,400
Enrollment target
1
Study location

NCT02060344: Active study of Cardiovascular Disease, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

NCT02060344 is a study of Cardiovascular Disease that is active but no longer recruiting, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 16,400 participants, above the 2,578-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (536% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02060344, a study of Cardiovascular Disease, is active but no longer recruiting, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

ACTIVE NOT RECRUITING
Registry status
16,400 participants
Enrollment target
1
Study location

Study Summary

The Hispanic Community Health Study / Study of Latinos (HCHS/SOL) is a multi-center epidemiologic study in Hispanic/Latino populations to determine the role of acculturation in the prevalence and development of disease, and to identify risk factors playing a protective or harmful role in Hispanics/Latinos.

Primary Outcome

This is a population-based cohort study of 16,400 Hispanic/Latinos. Objectives: * Examination of the cohort following a standardized protocol * Follow-up of the cohort to assess vital status, changes in health status, medication intake, and new cardiovascular and pulmonary events (fatal and non-fatal MI, heart failure, stroke, asthma, and COPD. * Understand the relationship between changes in risk factors and protective factors and onset of CV and pulmonary disease progression * Understand the

Conditions Studied

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 16,400 participants
Start Date 2006-01
Est. Completion 2032-11

What the registry record for NCT02060344 still lists

NCT02060344 is an observational study that tracks outcomes without assigning an intervention. Its 16,400 participants enrollment target places it among the larger protocols in the corpus, above the 2,578-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (536% higher).

The record links to 1 condition, with Cardiovascular Disease appearing as the primary indexed condition, and to 0 interventions.

NCT02060344 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT02060344 about?

NCT02060344 is a clinical study titled "Hispanic Community Health Study / Study of Latinos". The Hispanic Community Health Study / Study of Latinos (HCHS/SOL) is a multi-center epidemiologic study in Hispanic/Latino populations to determine the role of acculturation in the prevalence and development of disease, and to identify risk factors playing a protective or harmful role in Hispanics/L...

What is the current status of trial NCT02060344?

This trial is currently active not recruiting. The enrollment target is 16,400 participants. The study started on 2006-01. Estimated completion is 2032-11.

What conditions does trial NCT02060344 study?

This clinical trial studies the following conditions: Cardiovascular Disease.

Who is sponsoring clinical trial NCT02060344?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02060344 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02060344's enrollment target sits among peer trials

16,400 6th of 137 higher than 132 of 137 other Cardiovascular Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06951867 · 16,640 participants

    Tezspire Cardiac Events PASS

  • NCT01737528 · 16,000 participants

    STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)

  • NCT06380114 · 16,000 participants · NA

    Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination

  • NCT06948838 · 16,895 participants · NA

    Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02060344, the US trial registry maintained by the National Library of Medicine. NCT02060344 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.